Context is everything: extrinsic signalling and gain-of-function p53 mutants

被引:39
作者
Amelio, Ivano [1 ,2 ]
Melino, Gerry [1 ,3 ]
机构
[1] Univ Roma Tor Vergata, Dept Expt Med, TOR, I-00133 Rome, Italy
[2] Univ Nottingham, Sch Life Sci, Nottingham, England
[3] Univ Cambridge, Dept Pathol, Toxicol Unit, Tennis Court Rd, Cambridge CB2 1QP, England
基金
英国医学研究理事会;
关键词
MOLECULAR-MECHANISMS; CANCER; TAP73; DEATH; METASTASIS; METABOLISM; EXPRESSION; APOPTOSIS; PARTNERS; FAMILY;
D O I
10.1038/s41420-020-0251-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The TP53 genomic locus is a target of mutational events in at least half of cancers. Despite several decades of study, a full consensus on the relevance of the acquisition of p53 gain-of-function missense mutants has not been reached. Depending on cancer type, type of mutations and other unidentified factors, the relevance for tumour development and progression of the oncogenic signalling directed by p53 mutants might significantly vary, leading to inconsistent observations that have fuelled a long and fierce debate in the field. Here, we discuss how interaction with the microenvironment and stressors might dictate the gain-of-function effects exerted by individual mutants. We report evidence from the most recent literature in support of the context dependency of p53 mutant biology. This perspective article aims to raise a discussion in the field on the relevance that context might have on p53 gain-of-function mutants, assessing whether this should generally be considered a cell non-autonomous process.
引用
收藏
页数:7
相关论文
共 69 条
  • [31] Koga T, 2001, INT J CANCER, V95, P232, DOI 10.1002/1097-0215(20010720)95:4<232::AID-IJC1040>3.0.CO
  • [32] 2-5
  • [33] Control of metabolism by p53-Cancer and beyond
    Labuschagne, Christiaan F.
    Zani, Fabio
    Vousden, Karen H.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (01): : 32 - 42
  • [34] CANCER - P53, GUARDIAN OF THE GENOME
    LANE, DP
    [J]. NATURE, 1992, 358 (6381) : 15 - 16
  • [35] RAS in pancreatic cancer
    Lanfredini, Simone
    Thapa, Asmita
    O'Neill, Eric
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2019, 47 : 961 - 972
  • [36] Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
    Lang, GA
    Iwakuma, T
    Suh, YA
    Liu, G
    Rao, VA
    Parant, JM
    Valentin-Vega, YA
    Terzian, T
    Caldwell, LC
    Strong, LC
    El-Naggar, AK
    Lozano, G
    [J]. CELL, 2004, 119 (06) : 861 - 872
  • [37] p53: master of life, death, and the epigenome
    Laptenko, Oleg
    Prives, Carol
    [J]. GENES & DEVELOPMENT, 2017, 31 (10) : 955 - 956
  • [38] Skn-1a/Oct-11 and ΔNp63α exert antagonizing effects on human keratin expression
    Lena, Anna Maria
    Cipollone, Rita
    Amelio, Ivano
    Catani, Maria Valeria
    Ramadan, Safaa
    Browne, Gareth
    Melino, Gerry
    Candi, Eleonora
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (04) : 568 - 573
  • [39] p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs
    Leonova, Katerina I.
    Brodsky, Leonid
    Lipchick, Brittany
    Pal, Mahadeb
    Novototskaya, Liliya
    Chenchik, Alex A.
    Sen, Ganes C.
    Komarova, Elena A.
    Gudkov, Andrei V.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (01) : E89 - E98
  • [40] Reviewing the future of the p53 field
    Levine, Arnold J.
    [J]. CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) : 1 - 2